NanoViricides
NNVC
#10545
Rank
NZ$62.22 M
Marketcap
NZ$2.44
Share price
3.81%
Change (1 day)
-18.39%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2023 (TTM): NZ-$0.96

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$0.78. In 2022 the company made an earnings per share (EPS) of NZ-$1.07 an increase over its 2021 EPS that were of NZ-$1.37.

EPS history for NanoViricides from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.96-9.59%
2022NZ-$1.07-22.08%
2021NZ-$1.37-52.47%
2020NZ-$2.88-22.12%
2019NZ-$3.70-5.88%
2018NZ-$3.93-30.94%
2017NZ-$5.69-20%
2016NZ-$7.11111.85%
2015NZ-$3.36-27.38%
2014NZ-$4.62-55.17%
2013NZ-$10.3156.76%
2012NZ-$6.5815.63%
2011NZ-$5.69-8.57%
2010NZ-$6.2266.67%
2009NZ-$3.7315.38%
2008NZ-$3.24-21.67%
2007NZ-$4.13-17.02%
2006NZ-$4.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ-$5.51 604.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-325.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.04-1,127.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.12-753.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ-$2.70 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.56 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA